Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DML6TAS)

Drug Name

OPI-1002 Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Acute kidney injury	GB60	Phase 2	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Investigative Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting P53 messenger RNA (TP53 mRNA)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Cenersen	DMMN21R	Acute myeloid leukaemia	2A60	Phase 2	[2]
AHL	DMVZLIB	Hearing disorder	AB50-AB57	Investigative	[2]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

References

1	2011 Pipeline of Quark Pharm.
2	Phase 2 randomized study of p53 antisense oligonucleotide (cenersen) plus idarubicin with or without cytarabine in refractory and relapsed acute myeloid leukemia. Cancer. 2012 Jan 15;118(2):418-27.